Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

An epigenetic blockade of cognitive functions in the neurodegenerating brain.

Authors: Graff, J  Rei, D  Guan, JS  Wang, WY  Seo, J  Hennig, KM  Nieland, TJ  Fass, DM  Kao, PF  Kahn, M  Su, SC  Samiei, A  Joseph, N  Haggarty, SJ  Delalle, I  Tsai, LH 
Citation: Graff J, etal., Nature. 2012 Feb 29;483(7388):222-6. doi: 10.1038/nature10849.
Pubmed: (View Article at PubMed) PMID:22388814
DOI: Full-text: DOI:10.1038/nature10849

Cognitive decline is a debilitating feature of most neurodegenerative diseases of the central nervous system, including Alzheimer's disease. The causes leading to such impairment are only poorly understood and effective treatments are slow to emerge. Here we show that cognitive capacities in the neurodegenerating brain are constrained by an epigenetic blockade of gene transcription that is potentially reversible. This blockade is mediated by histone deacetylase 2, which is increased by Alzheimer's-disease-related neurotoxic insults in vitro, in two mouse models of neurodegeneration and in patients with Alzheimer's disease. Histone deacetylase 2 associates with and reduces the histone acetylation of genes important for learning and memory, which show a concomitant decrease in expression. Importantly, reversing the build-up of histone deacetylase 2 by short-hairpin-RNA-mediated knockdown unlocks the repression of these genes, reinstates structural and synaptic plasticity, and abolishes neurodegeneration-associated memory impairments. These findings advocate for the development of selective inhibitors of histone deacetylase 2 and suggest that cognitive capacities following neurodegeneration are not entirely lost, but merely impaired by this epigenetic blockade.

Annotation

Disease Annotations
Objects Annotated

Additional Information

 
RGD Object Information
RGD ID: 9590324
Created: 2014-11-25
Species: All species
Last Modified: 2014-11-25
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.